Influence of surgeon specialization upon the results of colon cancer surgery. Usefulness of propensity scores

Size: px
Start display at page:

Download "Influence of surgeon specialization upon the results of colon cancer surgery. Usefulness of propensity scores"

Transcription

1 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página /2008/100/7/ REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright 2008 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol N. 7, pp , 2008 ORIGINAL PAPERS Influence of surgeon specialization upon the results of colon cancer surgery. Usefulness of propensity scores D. Martínez-Ramos, J. Escrig-Sos, J. M. Miralles-Tena, M. I. Rivadulla-Serrano, J. M. Daroca-José and J. L. Salvador Sanchís Service of General and Digestive Surgery. Castellón General Hospital. Spain ABSTRACT Introduction: surgeon influence on colorectal cancer surgery outcomes has been repeatedly studied in the scientific literature, but conclusions have been contradictory. Here we study whether surgeon specialization is a determinant factor for outcome in these patients. The importance of propensity scores (PS) in surgical research is also studied. Patients and methods: a retrospective study was performed and medical records were reviewed for 236 patients who were intervened for colon cancer in Castellon General Hospital (Spain). Cases were divided into two groups (specialist and non-specialist surgeons), and both 5-year surveillance and disease free survival were compared. Comparisons were first made with no adjustments, and then subsequently using PS analysis. Results: the initial (non-adjusted) analysis was clearly favourable for the specialist surgeon group (5-year surveillance, 64.3 vs. 79.3%, p = 0.028). After adjusting for PS no statistical significance was obtained. Conclusions: surgeon specialization had no significant impact on patient outcome after colon cancer surgery. Propensity score analysis is an important tool in the analysis of surgical non-randomized studies, particularly when events under scrutiny are rare. Key words: Colon cancer. Outcomes. Specialization. Propensity scores. RESUMEN Introducción: la influencia del factor cirujano en el cáncer colorrectal se ha estudiado de manera reiterada en literatura científica, pero los resultados han sido contradictorios. Se plantea en este estudio si la especialización del cirujano es un factor determinante del pronóstico en estos pacientes. Asimismo, se valora la importancia de los índices de propensión (PS) en el análisis de los resultados. Pacientes y métodos: se planteó un estudio retrospectivo con revisión de las historias clínicas de 236 pacientes sometidos a cirugía por cáncer de colon en el Hospital General de Castellón. Se establecieron dos grupos de cirujanos (especialista y no especialista), comparando los resultados en cuanto a supervivencia y en cuanto a intervalo libre de enfermedad a los 5 años. Inicialmente, se realizaron las comparaciones sin el ajuste de los resultados y, posteriormente, utilizando los PS. Resultados: el primer análisis de los resultados (sin ajuste) fue claramente favorable al grupo de cirujanos especialistas (supervivencia a los 5 años del 64,3 frente al 79,3%, p = 0,028). No obstante, cuando se ajustó mediante los PS, no se obtuvo dicha significación estadística. Conclusiones: no se ha podido demostrar que la especialización del cirujano sea un factor determinante del pronóstico en los pacientes sometidos a cirugía por cáncer de colon. Los índices de propensión pueden ser de gran utilidad para el ajuste de los resultados en estudios retrospectivos no aleatorizados, especialmente cuando el factor de estudio es poco frecuente. Palabras clave: Cáncer de colon. Resultados. Especialización. Índices de propensión. Martínez-Ramos D, Escrig-Sos J, Miralles-Tena JM, Rivadulla-Serrano MI, Daroca-José JM, Salvador Sanchís JL. Influence of surgeon specialization upon the results of colon cancer surgery. Usefulness of propensity scores. Rev Esp Enferm Dig 2008; 100: Received: Accepted: Correspondence: David Martínez-Ramos. Servicio de Cirugía General y Digestiva. Hospital General de Castellón. Avda. Benicàssim, s/n Castellón, Spain. davidmartinez@comcas.es INTRODUCTION The influence of the surgeon factor upon surgical results has been widely analyzed for different types of cancer in the literature worldwide (1,2). Colon cancer has

2 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página D. MARTÍNEZ-RAMOS ET AL. REV ESP ENFERM DIG (Madrid) been no exception in this respect, and many authors have examined the potential relationship between extent of surgeon specialization in colorectal surgery and surgical results obtained (3-20). However, these comparative studies (specialized versus non-specialized surgeons) have not always exhibited the methodological guarantees required to draw conclusions based on true scientific evidence. Thus, while it is true that randomized, prospective clinical trials eliminate biases due to the biological characteristics of patients and their tumors (age, sex, tumor stage, comorbidity, etc.) by distributing them in a balanced manner in both study groups, retrospective studies are unable to guarantee such true randomization. In other words, non-randomized studies may present important imbalances in the distribution of characteristics inherent in each tumor and patient, and this in turn can condition and bias the results obtained. In order to lessen the influence of confounding factors in non-randomized analyses, in 1983 Rosenbaum and Rubin (21) introduced the concept of propensity score (PS). This score is a value of between 0 and 1 indicating the probability that a given patient (with certain biological characteristics) will be allotted to one study branch or another in the absence of randomization (22,23). With certain limitations, when results are adjusted using this probability, it can be assumed that the characteristics of patients capable of influencing study results will be distributed in a quasi-randomized manner. The present study analyzes the influence of the surgeon factor (specialist versus non-specialist) upon the results of colon cancer surgery, and examines the importance of PSs in this type of comparative analysis. MATERIAL AND METHODS In order to secure the study objectives, we used data corresponding to 236 patients operated upon for colon cancer in Castellón General Hospital (Castellón, Spain) between years 1995 and All patients included were subjected to tumor resection with either healing or palliative intent. We therefore excluded all interventions without resection of the primary tumor, and cases of rectal cancer. The purpose of selecting this study period was to ensure a minimum follow-up of 5 years. To establish propensity scores (PSs), use was made of logistic regression in which the outcome variable was type of surgeon. As predictive variables we used those parameters in our database which theoretically could influence the outcome of surgery, and thus of the disease. Likewise, the selected variables were not allowed to depend on surgeon choice or intervention, and could not correspond to case outcome in terms of survival and disease-free interval since both patient survival and disease-free interval constituted the primary endpoints of the analysis. The selected variables were related to patients (e.g., age and serious comorbidity); potential difficulty of the operation; tumor localization; and tumor baseline characteristics (e.g., Dukes stage and histological grade). A new variable was then entered in the database, consisting of the probability derived from the logistic model i.e., the probability, given these predictive variables, that each case was treated by the corresponding surgeon. In this study, the aforementioned probability constitutes the PS. Serious comorbidity was taken to be the presence of risk disorders under treatment at the time of surgery: heart or liver disease, renal failure, diabetes, chronic pulmonary disease, and peripheral vascular accidents. Right-side tumors were defined as those primary lesions located between the cecum and the two proximal thirds of the transverse colon, while left-side tumors were taken to be those primary tumors located between the distal third of the transverse colon and the zone immediately proximal to the rectosigmoid junction. The Dukes classification comprised the classical Stages A, B and C, along with another group (Stage D) comprising cases with metastasis synchronic to surgery, and which in all cases affected the liver. Specialized surgeons were taken to be those belonging to the Coloproctology Section (3 surgeons), while nonspecialized surgeons were taken to be the rest of surgeons in the Service that had performed some surgery for colon cancer (8 surgeons). In our Service there is no formal pre-established protocol for distributing elective colon cancer surgery between the two surgeon groups. We first analyzed the variables corresponding to baseline characteristics for patients and tumors, as well as the results of treatment in terms of patient survival and disease-free interval, without any type of adjustment, for both groups of surgeons. Quantitative variables were expressed as mean ± standard deviation (SD), while qualitative variables were expressed as frequency and relative percentage. Student s t-test was used for quantitative variables, Fisher s exact test for qualitative variables, and the Kaplan- Meier method with log-rank for analyzing survival. Subsequently we analyzed general patient survival and disease-free interval (time to disease relapse in cases without initially diagnosed metastases) based on Cox s regression analysis. In this multivariate test we only included as predictive variable the type of surgeon, and the PS as adjusting element. The STATA version 9 package was used for the statistical analyses. Statistical significance was accepted for p < RESULTS Of the 236 patients included in the study, 127 (53.8%) were males and 109 (46.2%) females. Mean age was 67.7 ± 12 years, with a minimum of 30 years and a maximum of 92 years. Tumors were located in 154 cases (65.3%) on the left side of the colon, and in 82 cases (34.7%) on the right side. In 148 patients (62.7%) we identified some type of comorbidity prior to surgery. The distribution by

3 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página 389 Vol N. 7, 2008 INFLUENCE OF SURGEON SPECIALIZATION UPON THE RESULTS 389 OF COLON CANCER SURGERY. USEFULNESS OF PROPENSITY SCORES Dukes stages was as follows: Stage A, 31 patients (13%); Stage B, 105 patients (44%); Stage C, 72 patients (31%); and Stage D, 28 patients (12%). The histological grading of tumors was as follows: GX, 2 patients; G1, 140 patients (59.3%); G2, 85 patients (36%); G3, 9 patients (4%). Mean anesthetic time was ± 51 minutes. In 97 patients (41%) some positive lymph node was isolated the mean number of lymph nodes examined per patient was 10.4 ± 7 nodes. No immediate postoperative complications were recorded in 191 patients (80.9%). Six cases of surgical wound infection were documented, along with 3 cases of evisceration, 4 suture failures, 18 other complications, and 14 deaths (6%). In relation to follow-up, the overall 5-year survival rate was 64.1%, with death due to tumor disease in 72 cases (31%). The global 5-year disease-free survival rate was 71.5%. The group of specialized surgeons carried out a total of 111 operations, representing an average of 7.4 operations a year per surgeon, while the non-specialized surgeons performed a total of 125 operations (3 operations/year/surgeon on average). Tables I and II show the results obtained after a comparative analysis of both groups, with no adjustment for patient distribution. This study showed the only factors reaching statistical significance to be Dukes stage (more synchronic metastases in the group of non-specialized surgeons, and more cases of positive lymph nodes among the specialists) and the global 5-year survival rate (greater in the group of specialized surgeons) (Fig. 1). In other words, in the absence of PS adjustment of results, specialized surgeons yielded better results in terms of the probability of 5-year survival, with a difference of 15% (64.3 versus 79.3% in the case of non-specialized surgeons). Other factors, such as the Table I. Baseline characteristics of the patients and tumors Non-specialized Specialized P surgeon surgeon value Number of patients Age 67.9 ± ± * Comorbidity Yes 77 (52%) 71 (48%) No 48 (55%) 40 (45%) 0.788** Tumor location Right 40 (49%) 42 (51%) Left 85 (55%) 69 (45%) 0.411** Dukes stage A 18 (58%) 13 (42%) B 59 (56%) 46 (44%) C 29 (40%) 43 (60%) 0.049** D 19 (68%) 9 (32%) Histological grade Indeterminate 2 0 G1 (well differentiated) 74 (53%) 66 (47%) G2 (Intermediate) 45 (53%) 40 (47%) 0.710** G3 (poorly differentiated) 4 (44%) 5 (56%) Expressed as mean ± standard deviation (SD); *Student t-test; **Fisher exact test. number of lymph nodes analyzed and postoperative complications, bordered on statistical significance. This could be interpreted as indicating a certain tendency in the group of specialized surgeons to obtain a comparatively larger number of lymph nodes and different postoperative complications. In this analysis there were no differences in disease-free survival between the two study groups. Despite these results clearly favorable to the group of specialized surgeons, PS adjustment in the Cox regression analysis for survival and disease relapse yielded the Table II. Results of surgical treatment prior to propensity scores adjustment Non-specialized Specialized P surgeon surgeon value Number of patients Anesthesia time (minutes) ± ± * Lymph nodes studied 9,6 ± ± * Positive lymph nodes 1.2 ± ± * Postoperative complications No 101 (81%) 90 (81%) Wound infection 1 (1%) 5 (4%) Evisceration 1 (1%) (2%) 0.078** Suture failure ( ) 4 (3%) 0 Death ( ) 10 (8%) 4 (4%) Other 8 (6%) 10 (9%) Death due to disease No 79 (48%) 85 (52%) Yes 46 (64%) 26 (36%) 5-year survival rate (Kaplan-Meier) 64.3% 79.3% 0.028*** Tumor relapse No 102 (56%) 79 (43%) Yes 23 (42%) 32 (58%) 5-year disease-free survival (Kaplan-Meier) 77.8% 75.4% 0.197*** Expressed as mean ± standard deviation (SD); ( ): particular for suture failure, p = 0.177**; ( ): particular for death, p = 0,125**; *Student t-test; **Fisher exact test; ***Log-rank test. Fig. 1. Probability of patient survival according to the Kaplan-Meier method for specialized and non-specialized surgeons. Results prior to adjustment.

4 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página D. MARTÍNEZ-RAMOS ET AL. REV ESP ENFERM DIG (Madrid) results shown in table III. After adjustment, it was seen that the p-value for PS in relation to tumor relapse was close to 1 (p = 0.92), i.e., clearly no significant, while in the case of survival, the value was under (i.e., highly significant). In other words, the distribution of patients between both types of surgeons exerted very little influence upon the results in relation to relapsing disease, but it strongly conditioned differences in global survival. Thus, the differences obtained as a result of the analysis of results without adjustment would not be attributable to the extent of surgeon specialization but to differences in the probability of patients being allotted to one surgeon group or the other, according to their baseline characteristics (age, comorbidity, side of tumor location, Dukes stage and histological grade, jointly grouped in the PS). In sum, we have not been able to demonstrate that the surgeon factor (relating to specialization) influences general survival and disease-free interval in our colon cancer patients. Table III. Cox regression and propensity scores adjustments for tumor relapse and patient survival Hazard 95% confidence P ratio interval value Tumor relapse Specialized surgeon to * Propensity score 0.921* Survival Specialized surgeon to * Propensity < 0.001** *Non significant; **Very significant. DISCUSSION The degree of surgeon specialization has been shown to be an independent prognostic factor for different types of complex and infrequent surgical procedures such as pancreatectomy, esophagectomy, pneumonectomy, liver resection or pelvic exenteration (1). In colorectal cancer, however, findings are contradictory. McArdle and Hole (10), among other authors (7,20), reported that surgeons with greater experience or specialized in colorectal surgery obtained better results in terms of patient survival and disease relapse versus non-specialized surgeons. Similar findings were published by Harmon et al. (5) and Schrag et al. (17,19), though unlike in the case of McArdle and Hole (10), these authors considered the volume of patients attended in the hospital to be a more important factor than the degree of surgeon specialization. However, while statistically significant, the difference in postoperative mortality after colon cancer surgery between hospitals with a greater or lesser volume of patients was only 2% (16). These results are in contrast with those obtained by Hermanek et al. (6), who reported a similar disease relapse rate between surgeons with fewer than (15) rectal surgical operations and those with comparatively greater experience. Two additional studies (8,13) likewise reported no statistically significant relationship between number of cases per surgeon and patient survival. Likewise, Mella et al. (11), in a series of 3,221 patients with colorectal cancer, found no differences in postoperative survival between a group of surgeons self-defined as being experts and another group considered to lack such expertise. Simunovic et al. (19) recorded no differences in the survival of patients subjected to specific colon cancer surgery in Ontario (Canada) between hospitals with a greater or lesser volume of treated patients. In this context, the present study identified no statistically significant differences in terms of the global 5-year survival rate or disease-free survival between the group of specialized surgeons and the group of non-specialized surgeons. However, the main limitation of our study is the definition of the concept of a surgeon specialized in colorectal surgery. In effect, at present there are no national or international criteria for defining such specialization or expertise in oncological colon surgery. In some cases, the definition of a specialized surgeon has been based on the number of patients operated upon by the surgeon (9) or hospital (18), membership in some specific coloproctology association (16,20), years as a specialist (7), possession of a board title in coloproctology (14,15), or even self-definition as specialist with a particular interest in coloproctology (11). In other cases, as in our study, the distinction between specialized and non-specialized surgeons is based on peer assessment according to certain previously established criteria (10). In the present study, the classification was exclusively based on whether a surgeon belonged to the Coloproctology Section of our Service of General Surgery. Although it is logically necessary to define what is meant by a surgeon specialized in coloproctology, due consideration is also required of the limitations differences in concept may impose upon the comparative analysis of the results obtained. Another difference to be taken into account is that the present study refers only to colon cancer with the exclusion of all rectal lesions. As is well known, rectal malignancies present important differences in terms of technical difficulty and as regards adjuvant and neoadjuvant treatments, compared with cancers located in the colon. As a result, our findings cannot be applied to rectal tumors. On the other hand, the present study has demonstrated the usefulness of applying propensity scores (PSs). In effect, in the initial analysis without adjustment for confounding factors, the results were clearly favorable to specialized surgeons (5-year survival rate 64.3% vs. 79.3% among the non-specialists, p = 0.028). However, such statistical significance was lost after applying a PS adjustment. According to this analysis, certain patients had an a priori greater probability of being assigned to one surgeon group or the other a fact that introduced an important bias in the initial results. Following PS adjustment, the surgeon factor was not found to exert an impor-

5 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página 391 Vol N. 7, 2008 INFLUENCE OF SURGEON SPECIALIZATION UPON THE RESULTS 391 OF COLON CANCER SURGERY. USEFULNESS OF PROPENSITY SCORES tant influence in the prognosis of patients subjected to colon cancer surgery. The slight and no significant tendency towards improved patient survival in the specialized surgeon group that remained after adjustment (hazard ratio < 1, table III) could have been related to the fact that these surgeons operated on fewer cases presenting with metastases at the time of surgery. In contrast, the group of specialists showed a slight and again no significant tendency towards poorer performance (hazard ratio > 1, table III), in terms of time to disease relapse. This may have been because they operated upon more cases with positive lymph nodes (Dukes Stage C), and upon fewer patients in Stages A and B. An added advantage of propensity scores is that they consider the influence (no matter how small) of variables which individually show no significant differences with respect to compared groups. Although the comparison of surgical results is one of the elements required for evidence-based surgical practice, such comparisons must be established with rigor in order to avoid biased conclusions and dire consequences for patients. Thus, when comparisons are made in the context of randomized and controlled clinical trials, patients are randomly allotted to the different study groups or arms, and it therefore can be assumed that differences between groups are minimal in terms of confounding factors. However, these studies cannot always be conducted in a randomized and prospective manner due to a number of reasons (particularly ethical and organizational in nature). In such situations use must be made of case series, cohorts or case-control designs, as in our study. In these non-randomized studies, confounding factors are generally an important problem, and a multivariate analysis is often used to adjust for such factors. However, in some cases this type of analysis, applied directly to the study objective, may exceed its applicability - particularly when the study result is unusual (e.g., death of patients in early tumor stages) or (in other words) when the number of confounding factors is too large for the sample used. In these cases, propensity scores (PSs) offer a mathematically valid alternative to direct multivariate analysis (22,23). Thus, PSs represent the probability (between 0 and 1) that a given patient will receive one treatment instead of the treatment of the other control group, i.e., the probability of being assigned to a given study group on the basis of a series of baseline characteristics (potential confounding factors) using a logistic regression model as intermediate step towards the definitive analysis. The main difference between direct multivariate analysis and PS adjustment is that the former involves adjustment according to a series of baseline characteristics paying special attention to the relationship between these characteristics and the final result while propensity scoring focuses on the relationship between baseline characteristics and the primary endpoint of the study (in our case type of surgeon), with use in a second step as an element for adjustment in the final analysis of the primary endpoint. In this way, propensity scoring attempts an a posteriori reconstruction of a situation similar to randomization, known as quasi-randomization (22). The analytical techniques most commonly used for calculating PS in medicine are matching, stratification and logistic regression. In the present study we used the latter approach, since it is simpler to apply versus the other techniques, and we deliberately included age, comorbidity, side of tumor location, tumor stage, and histological grade as potential confounding factors since these are the factors commonly used for the adjustment of surgical results in this disease (16). However, it is important to take into account that propensity scoring, in the same way as the direct multivariate analysis, is unable to adjust for unknown or unavailable confounding factors, and the presence of any such factor could alter the final result (22). This constitutes another limitation of the study, but is exclusively inherent to the methodology. The usefulness of PS goes well beyond what has been presented here for the comparison of results between specialized and non-specialized surgeons, since the technique can be used for comparing results in any setting, such as two surgical techniques (laparoscopic versus open surgery), two adjuvant therapies (adjuvant chemotherapy versus neoadjuvant chemotherapy) or two hospital centers (reference versus secondary), etc. Knowledge of the indications for PS, and the consequences and limitations involved, may be of great help for avoiding important errors when drawing conclusions from studies. In general, on comparing two groups in non-randomized studies, some type of adjustment for potential confounding factors must be established. Am analysis of the distribution of these factors between the two groups, with the observation of no statistically significant differences, does not guarantee that groups are comparable and can be analyzed with conventional inferential (non-multivariate) statistical tests. This erroneous approach is quite widespread in the literature (9,24,25), and should be avoided. Thus, while propensity scores are not the only adjustment tool available, in studies such as our own they may be very useful. CONCLUSION In the present study we were unable to show extent of surgeon specialization as a determining factor for the prognosis of patients subjected to colon cancer surgery. Rather, the results were found to be influenced by the baseline characteristics of patient and tumor. On the other hand, our study demonstrates the usefulness of propensity scores in adjusting the results of non-randomized retrospective studies, particularly when the study factor is infrequent, and illustrates how findings can be drastically modified as a result. Such propensity scores can be applied in many clinical research settings, avoiding biases introduced by the non-randomized distribution of patients in one study group or another.

6 D. MARTINEZ RAMOS -:Maquetación 1 19/9/08 11:23 Página D. MARTÍNEZ-RAMOS ET AL. REV ESP ENFERM DIG (Madrid) REFERENCES 1. Begg CB, Cramer LD, Hoskins WJ, et al. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: Layne C. Does practice really make perfect? Ann Intern Med 2003; 139: García-Granero E. El factor cirujano y la calidad de la cirugía en el pronóstico del cáncer de recto. Implicaciones en la especialización y organización. Cir Esp 2006; 79: García-Granero E, Martí-Obiol R, Gómez-Barbadillo, et al. Impact of surgeon organization and specialization in rectal cancer outcome. Colorectal Dis 2001; 3: Harmon JW, Tang DG, Gordon TA, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 1999; 230: Hermanek P, Weibelt H, Staimmer D, et al. Prognostic factors of rectum carcinoma experience of the German Multicenter Sudy SGCRC. German Study Group Colo-Rectal carcinoma. Tumori 1991; 81: Holm T, Johansson H, Cedermark B, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997; 84: Kee F, Wilson, RH, Harper C, et al. Influence of hospital and clinician workload on survival from colorectal cancer: Cohort study. BMJ 1999; 318: Luján J, Hernández Q, Valero G, et al. Influencia del factor cirujano en el tratamiento quirúrgico del cáncer de recto con quimiorradioterapia preoperatoria. Estudio comparativo. Cir Esp 2006; 79: McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg 2004; 91: Mella J, Biffin A, Radcliffe AG, et al. Population-based audit of colorectal cancer management in two UK health regions. Br J Surg 1997; 84: Meyerhardt JA, Catalano PJ, Schrag D, et al. Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med 2003; 139: Parry JM, Collins S, Mathers J, et al. Influence of volume of work on the outcome of treatment for patients with colorectal cancer. Br J Surg 1999; 86: Porter GA, Soskolne CL, Yakimets WW, et al. Surgeon-related factors and outcomes in rectal cancer. Ann Surg 1998; 227: Rosen L, Stasikk JJ, Reed JF, et al. Variations in colon and rectal surgical mortality. Comparison of specialties with a state-legislated database. Dis Colon Rectum 1996; 39: Schrag D, Cramer LD, Bach PB, et al. Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000; 284: Schrag D, Panageas KS, Riedel E, et al. Hospital and surgeon procedure volume as predictors of outcome following rectal cancer resection. Ann Surg 2002; 236: Schrag D, Panageas KS, Riedel E, et al. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 2003; 83: Simunovic M, Rempel E, Thériault ME, et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. Can J Surg 2006; 49: Smith JAE, King PM, Lane RHS, et al. Evidence of the effect of specialization on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 2003; 90: Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: Adamina M, Guller U, Weber WP, et al. Propensity scores and the surgeon. Br J Surg 2006; 93: Newgard CD, Hedges JR, Arthur M, et al. Advanced statistics: The propensity score a method for estimating treatment effect in observational research. Acad Emerg Med 2004; 44: Escrig-Sos J. Comparación de resultados quirúrgicos: un mínimo control, por favor. Cir Esp 2006; 80: Luján-Mompeán JA. Respuesta de los autores. Cir Esp 2006; 80:

Outcome following surgery for colorectal cancer

Outcome following surgery for colorectal cancer Outcome following surgery for colorectal cancer Colin S McArdle* and David J Hole *University Department of Surgery, Glasgow Royal Infirmary, Glasgow and Department of Public Health, University of Glasgow,

More information

Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node

Impact of the total number of harvested lymph nodes after colon cancer resections on survival in patients without involved lymph node 1130-0108/2010/102/5/296-301 REVISTA ESPAÑOLA DE ENFERMEDADES DIGESTIVAS Copyright 2010 ARÁN EDICIONES, S. L. REV ESP ENFERM DIG (Madrid) Vol. 102. N. 5, pp. 296-301, 2010 ORIGINAL PAPERS Impact of the

More information

Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer

Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Indeterminate Pulmonary Nodules in Patients with Colorectal Cancer Jai Sule 1, Kah Wai Cheong 2, Stella Bee 2, Bettina Lieske 2,3 1 Dept of Cardiothoracic and Vascular Surgery, University Surgical Cluster,

More information

After primary tumor treatment, 30% of patients with malignant

After primary tumor treatment, 30% of patients with malignant ESTS METASTASECTOMY SUPPLEMENT Alberto Oliaro, MD, Pier L. Filosso, MD, Maria C. Bruna, MD, Claudio Mossetti, MD, and Enrico Ruffini, MD Abstract: After primary tumor treatment, 30% of patients with malignant

More information

Abdominal subcutaneous adipose tissue as a predictor of high-grade renal cell carcinoma

Abdominal subcutaneous adipose tissue as a predictor of high-grade renal cell carcinoma ARTÍCULO ORIGINAL Rev Mex Urol. Abdominal subcutaneous adipose tissue as a predictor of high-grade renal cell carcinoma - Abstract BACKGROUND: pose tissue on the prognosis and aggressiveness of renal cell

More information

Rectal cancer will affect more than 41,000 people in the REVIEW. The Effect of Hospital and Surgeon Volume on Outcomes for Rectal Cancer Surgery

Rectal cancer will affect more than 41,000 people in the REVIEW. The Effect of Hospital and Surgeon Volume on Outcomes for Rectal Cancer Surgery CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1185 1193 REVIEW The Effect of Hospital and Surgeon Volume on Outcomes for Rectal Cancer Surgery TALYA SALZ* and ROBERT S. SANDLER *Department of Health

More information

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas

Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas 10 The Open Otorhinolaryngology Journal, 2011, 5, 10-14 Open Access Poor Outcomes in Head and Neck Non-Melanoma Cutaneous Carcinomas Kevin C. Huoh and Steven J. Wang * Head and Neck Surgery and Oncology,

More information

Stage III Colon Cancer Susquehanna Cancer Center Warren L Robinson, MD, FACP May 9, 2007

Stage III Colon Cancer Susquehanna Cancer Center Warren L Robinson, MD, FACP May 9, 2007 Stage III Colon Cancer Susquehanna Cancer Center 1997-21 Warren L Robinson, MD, FACP May 9, 27 Stage III Colon Cancer Susquehanna Cancer Center 1997-21 Colorectal cancer is the third most common cancer

More information

Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles

Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles I Congreso de GESIDA Madrid, 21-24 de Octubre del 2009. Supervivencia a 5 años de Pacientes Coinfectados por VHC-VIH Trasplantados Hepáticos: un Estudio de Casos y Controles José M. Miró, 1 Miguel Montejo,

More information

Best Papers. F. Fusco

Best Papers. F. Fusco Best Papers UROLOGY F. Fusco Best papers - 2015 RP/RT Oncological outcomes RP/RT IN ct3 Utilization trends RP/RT Complications Evolving role of elnd /Salvage LND This cohort reflects the current clinical

More information

Postoperative Mortality in Lung Cancer Patients

Postoperative Mortality in Lung Cancer Patients Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,

More information

Terapia neoadyuvante en cáncer de recto Estado del arte Mauricio Lema Medina MD Clínica de Oncología Astorga / Clínica SOMA - Medellín, Colombia

Terapia neoadyuvante en cáncer de recto Estado del arte Mauricio Lema Medina MD Clínica de Oncología Astorga / Clínica SOMA - Medellín, Colombia Terapia neoadyuvante en cáncer de recto Estado del arte Mauricio Lema Medina MD Clínica de Oncología Astorga / Clínica SOMA - Medellín, Colombia Temario Generalidades Adyuvancia en colon y recto FU / Capecitabina

More information

Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer

Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer Curr Oncol, Vol. 21, pp. 181-186 doi: http://dx.doi.org/10.3747/co.21.1963 DELAYED TIME TO ADJUVANT CHEMOTHERAPY ORIGINAL ARTICLE Factors associated with delayed time to adjuvant chemotherapy in stage

More information

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection

Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Long term survival study of de-novo metastatic breast cancers with or without primary tumor resection Dr. Michael Co Division of Breast Surgery Queen Mary Hospital The University of Hong Kong Conflicts

More information

How much colon should be resected?

How much colon should be resected? Colon Cancer Surgical Standard of Care and Operative Techniques Madhulika G. Varma MD Professor and Chief Section of Colorectal Surgery University of California, San Francisco How much colon should be

More information

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers

Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers 日大医誌 75 (1): 10 15 (2016) 10 Original Article Implications of Progesterone Receptor Status for the Biology and Prognosis of Breast Cancers Naotaka Uchida 1), Yasuki Matsui 1), Takeshi Notsu 1) and Manabu

More information

Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience

Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience Radiotherapy and Conservative Surgery For Merkel Cell Carcinoma - The British Columbia Cancer Agency Experience Poster No.: RO-0003 Congress: RANZCR FRO 2012 Type: Scientific Exhibit Authors: C. Harrington,

More information

RESEARCH ARTICLE. Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran

RESEARCH ARTICLE. Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran DOI:http://dx.doi.org/10.7314/APJCP.2016.17.1.159 RESEARCH ARTICLE Factors Affecting Survival in Patients with Colorectal Cancer in Shiraz, Iran Mohammad Zare-Bandamiri 1, Narges Khanjani 2 *, Yunes Jahani

More information

Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer

Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer ORIGINAL CONTRIBUTION Hospital Lymph Node Examination Rates and Survival After Resection for Colon Cancer Sandra L. Wong, MD, MS Hong Ji, MS Brent K. Hollenbeck, MD, MS Arden M. Morris, MD, MPH Onur Baser,

More information

17 th December 2008 Glasgow eprints Service

17 th December 2008 Glasgow eprints Service McMillan, D.C. and Hole, D.J. and McArdle, C.S. (2008) The impact of old age on cancer-specific and non-cancer-related survival following elective potentially curative surgery for Dukes A/B colorectal

More information

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC)

The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine Carcinoma (LCNC) Disclosure None Background Torino, Italy LCNC Rare tumor (2% to 3% all resected primary lung cancers) Preoperative

More information

Title: What is the role of pre-operative PET/PET-CT in the management of patients with

Title: What is the role of pre-operative PET/PET-CT in the management of patients with Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June

More information

Predictors in Determining Recurrence of Pancreatic Cancer

Predictors in Determining Recurrence of Pancreatic Cancer Predictors in Determining Recurrence of Pancreatic Cancer Lesly Almanzar Kean University Reed Johnson Luther College Alexandria Leonhardt Cornell College Evelyn Rodriguez Correa Pontifical Catholic University

More information

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database

Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Surgical Management of Metastatic Colon Cancer: analysis of the Surveillance, Epidemiology and End Results (SEER) database Hadi Khan, MD 1, Adam J. Olszewski, MD 2 and Ponnandai S. Somasundar, MD 1 1 Department

More information

Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery

Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery Impact of Screening Colonoscopy on Outcomes in Colon Cancer Surgery The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Ablative therapy, nonsurgical, for pulmonary metastases of soft tissue sarcoma, 279 280 Adipocytic tumors, atypical lipomatous tumor vs. well-differentiated

More information

Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry

Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry 2015;112:872 876 Natural History and Treatment Trends in Hepatocellular Carcinoma Subtypes: Insights From a National Cancer Registry PETER L. JERNIGAN, MD, KOFFI WIMA, MS, DENNIS J. HANSEMAN, PhD, RICHARD

More information

Introduction ORIGINAL RESEARCH

Introduction ORIGINAL RESEARCH Cancer Medicine ORIGINAL RESEARCH Open Access The effect of radiation therapy in the treatment of adult soft tissue sarcomas of the extremities: a long- term community- based cancer center experience Jeffrey

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adenocarcinoma, pancreatic ductal, laparoscopic distal pancreatectomy for, 61 Adrenal cortical carcinoma, laparoscopic adrenalectomy for, 114

More information

Lymph node ratio as a prognostic factor in stage III colon cancer

Lymph node ratio as a prognostic factor in stage III colon cancer Lymph node ratio as a prognostic factor in stage III colon cancer Emad Sadaka, Alaa Maria and Mohamed El-Shebiney. Clinical Oncology department, Faculty of Medicine, Tanta University, Egypt alaamaria1@hotmail.com

More information

Disclosures. I am a paid consultant for:

Disclosures. I am a paid consultant for: Surgical Sub-specialization: Colorectal Specialist Peter W. Marcello, M.D. Vice Chairman, Department of Colon & Rectal Surgery Lahey Clinic Burlington, Massachusetts Disclosures I am a paid consultant

More information

Extent of lymphadenectomy for esophageal squamous cell cancer: interpreting the post-hoc analysis of a randomized trial

Extent of lymphadenectomy for esophageal squamous cell cancer: interpreting the post-hoc analysis of a randomized trial Accepted Manuscript Extent of lymphadenectomy for esophageal squamous cell cancer: interpreting the post-hoc analysis of a randomized trial Vaibhav Gupta, MD PII: S0022-5223(18)33169-6 DOI: https://doi.org/10.1016/j.jtcvs.2018.11.055

More information

Deposited on: 4 November 2009

Deposited on: 4 November 2009 Roxburgh, C.S.D. and Crozier, J.E.M. and Maxwell, F. and Foulis, A.K. and Brown, J. and McKee, R.F. and Anderson, J.H. and Horgan, P.G. and McMillan, D.C. (2009) Comparison of tumour-based (Petersen Index)

More information

NIH Public Access Author Manuscript World J Urol. Author manuscript; available in PMC 2012 February 1.

NIH Public Access Author Manuscript World J Urol. Author manuscript; available in PMC 2012 February 1. NIH Public Access Author Manuscript Published in final edited form as: World J Urol. 2011 February ; 29(1): 11 14. doi:10.1007/s00345-010-0625-4. Significance of preoperative PSA velocity in men with low

More information

Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery

Local and Systemic Recurrence is the Achilles Heel of Cancer Surgery Ann Surg Oncol (2011) 18:603 607 DOI 10.1245/s10434-010-1442-0 EDITORIAL Local and Systemic Recurrence is the Achilles Heel of Cancer Louis A. Aliperti 1, Jarrod D. Predina 1, Anil Vachani 2, and Sunil

More information

Peritoneal Involvement in Stage II Colon Cancer

Peritoneal Involvement in Stage II Colon Cancer Anatomic Pathology / PERITONEAL INVOLVEMENT IN STAGE II COLON CANCER Peritoneal Involvement in Stage II Colon Cancer A.M. Lennon, MB, MRCPI, H.E. Mulcahy, MD, MRCPI, J.M.P. Hyland, MCh, FRCS, FRCSI, C.

More information

Age and factors associated with access and time to postoperative adjuvant chemotherapy in colon cancer: a French epidemiological study

Age and factors associated with access and time to postoperative adjuvant chemotherapy in colon cancer: a French epidemiological study Original Article Age and factors associated with access and time to postoperative adjuvant chemotherapy in colon cancer: a French epidemiological study Jean Capsec 1, Carole Lefebvre 1, Fabienne Chupé

More information

Neoadjuvant Therapy for Rectal Cancer is Overrated. Joon H. Lee, Research Resident University of Colorado 8/31/2009

Neoadjuvant Therapy for Rectal Cancer is Overrated. Joon H. Lee, Research Resident University of Colorado 8/31/2009 Neoadjuvant Therapy for Rectal Cancer is Overrated Joon H. Lee, Research Resident University of Colorado 8/31/2009 Objectives Brief overview of staging rectal cancer Current guidelines for evaluation and

More information

LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG

LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi

More information

Although the international TNM classification system

Although the international TNM classification system Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru

More information

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 14 (2005) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 14 (2005) 433 439 Index Note: Page numbers of article titles are in boldface type. A Abdominosacral resection, of recurrent rectal cancer, 202 215 Ablative techniques, image-guided,

More information

Management of Perforated Colon Cancers

Management of Perforated Colon Cancers Management of Perforated Colon Cancers Introduction Colon and rectal cancers are the most common gastrointestinal cancers. They are 3 rd most common and 2 nd most common causes of cancer deaths among men

More information

Treatment of Locally Advanced Rectal Cancer: Current Concepts

Treatment of Locally Advanced Rectal Cancer: Current Concepts Treatment of Locally Advanced Rectal Cancer: Current Concepts James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation

More information

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH

Laparoscopic Resection Of Colon & Rectal Cancers. R Sim Centre for Advanced Laparoscopic Surgery, TTSH Laparoscopic Resection Of Colon & Rectal Cancers R Sim Centre for Advanced Laparoscopic Surgery, TTSH Feasibility and safety Adequacy - same radical surgery as open op. Efficacy short term benefits and

More information

Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment

Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment ORIGINAL ARTICLE Differentiated Thyroid Cancer: Reclassification of the Risk of Recurrence Based on the Response to Initial Treatment Martínez MP, Lozano Bullrich MP, Rey M, Ridruejo MC, Bomarito MJ, Claus

More information

Analysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix

Analysis of Prognosis and Prognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix DOI 10.1007/s11805-009-0133-8 133 Analysis of rognosis and rognostic Factors of Cervical Adenocarcinoma and Adenosqumous Carcinoma of the Cervix Guangwen Yuan Lingying Wu Xiaoguang Li Manni Huang Department

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Abdominoperineal excision, of rectal cancer, 93 111 current controversies in, 106 109 extent of perineal dissection and removal of pelvic floor,

More information

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05

Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer. Cheol Min Kang 2018/04/05 Abstract No.: ABS-0075 Clinicopathological Factors Affecting Distant Metastasis Following Loco-Regional Recurrence of breast cancer 2018/04/05 Cheol Min Kang Department of surgery, University of Ulsan

More information

Lung cancer is a major cause of cancer deaths worldwide.

Lung cancer is a major cause of cancer deaths worldwide. ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,

More information

Clinical analysis of 29 cases of nasal mucosal malignant melanoma

Clinical analysis of 29 cases of nasal mucosal malignant melanoma 1166 Clinical analysis of 29 cases of nasal mucosal malignant melanoma HUANXIN YU and GANG LIU Department of Otorhinolaryngology Head and Neck Surgery, Tianjin Huanhu Hospital, Tianjin 300060, P.R. China

More information

Statistical aspects of surgery in clinical trials. Laurence Collette, PhD Statistics Department, EORTC, Brussels (BE)

Statistical aspects of surgery in clinical trials. Laurence Collette, PhD Statistics Department, EORTC, Brussels (BE) Statistical aspects of surgery in clinical trials Laurence Collette, PhD Statistics Department, EORTC, Brussels (BE) Employee of EORTC, non profit organization No conflict of interest to declare Surgery

More information

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva

Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Locoregional treatment Session Oral Abstract Presentation Saulo Brito Silva Background Post-operative radiotherapy (PORT) improves disease free and overall suvivallin selected patients with breast cancer

More information

Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery

Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery Zhobin Moghadamyeghaneh MD 1, Michael J. Stamos MD 1 1 Department of Surgery, University of California, Irvine Nothing to

More information

Follow up The way ahead. John Griffith

Follow up The way ahead. John Griffith Follow up The way ahead John Griffith Key Emerging Principles Risk stratified pathways of care Personalised care plan and treatment summary with a hand held record Information and education Remote monitoring

More information

Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma

Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma Int Surg 2014;99:512 517 DOI: 10.9738/INTSURG-D-13-00118.1 Glasgow Prognostic Score (GPS) Can Be a Useful Indicator to Determine Prognosis of Patients With Colorectal Carcinoma Tadahiro Nozoe, Rumi Matono,

More information

Management of colorectal cancer liver metastases

Management of colorectal cancer liver metastases Management of colorectal cancer liver metastases Aliakbarian M. M.D. Assistant professor of surgery Organ Transplant & Hepatopancreatobiliary Surgeon SUBJECTS The importance of surgical resection in colorectal

More information

National Bowel Cancer Audit. Detection and management of outliers: Clinical Outcomes Publication

National Bowel Cancer Audit. Detection and management of outliers: Clinical Outcomes Publication National Bowel Cancer Audit Detection and management of outliers: Clinical Outcomes Publication November 2017 1 National Bowel Cancer Audit (NBOCA) Detection and management of outliers Clinical Outcomes

More information

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type. Surg Oncol Clin N Am 16 (2007) 465 469 Index Note: Page numbers of article titles are in boldface type. A Adjuvant therapy, preoperative for gastric cancer, staging and, 339 B Breast cancer, metabolic

More information

Short and longterm outcomes after endoscopic resection of malignant polyps.

Short and longterm outcomes after endoscopic resection of malignant polyps. Short and longterm outcomes after endoscopic resection of malignant polyps. Short and longterm outcomes High risk features Lymph node metastasis Lymph node metastases sm1 sm2 sm3 Son 2008 3.1 % 14.9% 25.0

More information

Survival after Complete Mesocolic Excision (CME) for Right Sided Coloncancer Compared to Standard Surgery

Survival after Complete Mesocolic Excision (CME) for Right Sided Coloncancer Compared to Standard Surgery Send Orders for Reprints to reprints@benthamscience.net 6 The Open Surgery Journal, 213, 7, 6-1 Open Access Survival after Complete Mesocolic Excision () for Right Sided Coloncancer Compared to Standard

More information

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis

Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis Jpn J Clin Oncol 1997;27(5)305 309 Revisit of Primary Malignant Neoplasms of the Trachea: Clinical Characteristics and Survival Analysis -, -, - - 1 Chest Department and 2 Section of Thoracic Surgery,

More information

Complete surgical excision remains the greatest potential

Complete surgical excision remains the greatest potential ORIGINAL ARTICLE Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD,* Charles E. Eastridge, MD, Elizabeth A. Tolley,

More information

Propensity score methods to adjust for confounding in assessing treatment effects: bias and precision

Propensity score methods to adjust for confounding in assessing treatment effects: bias and precision ISPUB.COM The Internet Journal of Epidemiology Volume 7 Number 2 Propensity score methods to adjust for confounding in assessing treatment effects: bias and precision Z Wang Abstract There is an increasing

More information

Tratamiento adyuvante y neoadyuvante del cáncer renal en Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet.

Tratamiento adyuvante y neoadyuvante del cáncer renal en Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet. Tratamiento adyuvante y neoadyuvante del cáncer renal en 2017 Xavier Garcia del Muro Solans Institut Català d Oncologia Hospitalet. Barcelona Pronóstico del CR mediante un sistema integrado en 468 pts

More information

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008

Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Special Report Temporal Trends in Demographics and Overall Survival of Non Small-Cell Lung Cancer Patients at Moffitt Cancer Center From 1986 to 2008 Matthew B. Schabath, PhD, Zachary J. Thompson, PhD,

More information

Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER)

Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER) Propensity Score Analysis to compare effects of radiation and surgery on survival time of lung cancer patients from National Cancer Registry (SEER) Yan Wu Advisor: Robert Pruzek Epidemiology and Biostatistics

More information

The role of cytoreductive. nephrectomy in elderly patients. with metastatic renal cell. carcinoma in an era of targeted. therapy

The role of cytoreductive. nephrectomy in elderly patients. with metastatic renal cell. carcinoma in an era of targeted. therapy The role of cytoreductive nephrectomy in elderly patients with metastatic renal cell carcinoma in an era of targeted therapy Dipesh Uprety, MD Amir Bista, MD Yazhini Vallatharasu, MD Angela Smith, MA David

More information

Michał Mik, Łukasz Dziki, Radzisław Trzciński, Adam Dziki

Michał Mik, Łukasz Dziki, Radzisław Trzciński, Adam Dziki POLSKI PRZEGLĄD CHIRURGICZNY 2016, 88, 1, 2631 10.1515/pjs20160023 Risk factors of 30day mortality following surgery for colorectal cancer Michał Mik, Łukasz Dziki, Radzisław Trzciński, Adam Dziki Department

More information

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy

Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Korean J Hepatobiliary Pancreat Surg 2011;15:152-156 Original Article Treatment outcomes and prognostic factors of gallbladder cancer patients after postoperative radiation therapy Suzy Kim 1,#, Kyubo

More information

VQI literature review

VQI literature review VQI literature review Jaime Benarroch-Gampel, MD, MS Assistant Professor Emory University School of Medicine SEVSG Spring Meeting 04/28/2017 Article #1 J Vasc Surg 2017. epub ahead of print INTRODUCTION

More information

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea

Treatment Strategy for Non-curative Resection of Early Gastric Cancer. Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Treatment Strategy for Non-curative Resection of Early Gastric Cancer Jun Haneg Lee. Sungkyunkwan University, Samsung Medical Center, Seoul Korea Classic EMR/ESD data analysis style Endoscopic resection

More information

Advanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015

Advanced Pelvic Malignancy: Defining Resectability Be Aggressive. Lloyd A. Mack September 19, 2015 Advanced Pelvic Malignancy: Defining Resectability Be Aggressive Lloyd A. Mack September 19, 2015 CONFLICT OF INTEREST DECLARATION I have no conflicts of interest Advanced Pelvic Malignancies Locally Advanced

More information

LA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II

LA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II AUSL BA/4 Ospedale S. Paolo Bari U.O. Complessa di Chirurgia Toracica LA RADIOTERAPIA NEL TRATTAMENTO INTEGRATO DEL CANCRO DEL POLMONE NON MICROCITOMA NSCLC I-II stadio L opinione del chirurgo Francesco

More information

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer

Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,

More information

A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer.

A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric cancer. Biomedical Research 2018; 29 (2): 365-370 ISSN 0970-938X www.biomedres.info A study on clinicopathological features and prognostic factors of patients with upper gastric cancer and middle and lower gastric

More information

Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution

Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution Surg Today (2014) 44:1685 1691 DOI 10.1007/s00595-013-0748-5 ORIGINAL ARTICLE Difference in the recurrence rate between right- and left-sided colon cancer: a 17-year experience at a single institution

More information

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size

Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size GENERAL THORACIC Visceral Pleural Invasion Is Not Predictive of Survival in Patients With Lung Cancer and Smaller Tumor Size Elizabeth David, MD, Peter F. Thall, PhD, Neda Kalhor, MD, Wayne L. Hofstetter,

More information

Dynamic Allocation Methods: Why the Controversy?

Dynamic Allocation Methods: Why the Controversy? Dynamic Allocation Methods: Why the Controversy? Greg Pond Ph.D., P.Stat. Ontario Clinical Oncology Group Department of Oncology Department of Clinical Epidemiology and Biostatistics 11 December 2009 TRENDS

More information

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients British Journal of Obstetrics and Gynaecology November 1999, Vol106, pp. 1130-1136 Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients *E. J. Junor

More information

The effect of delayed adjuvant chemotherapy on relapse of triplenegative

The effect of delayed adjuvant chemotherapy on relapse of triplenegative Original Article The effect of delayed adjuvant chemotherapy on relapse of triplenegative breast cancer Shuang Li 1#, Ding Ma 2#, Hao-Hong Shi 3#, Ke-Da Yu 2, Qiang Zhang 1 1 Department of Breast Surgery,

More information

The role of cryotherapy in localized prostate cancer treatment: experience at the Hospital Central Sur de Alta Especialidad, PEMEX

The role of cryotherapy in localized prostate cancer treatment: experience at the Hospital Central Sur de Alta Especialidad, PEMEX ORIGINAL ARTICLE The role of cryotherapy in localized prostate cancer treatment: experience at the Hospital Central Sur de Alta Schroeder-Ugalde Iván Mauricio, 1 Xochipitécatl-Muñoz D. Juan, 2 Castellanos-Hernández

More information

Treatment strategy of metastatic rectal cancer

Treatment strategy of metastatic rectal cancer 35.Schweizerische Koloproktologie-Tagung Treatment strategy of metastatic rectal cancer Gilles Mentha University hospital of Geneva Bern, January 18th, 2014 Colorectal cancer is the third most frequent

More information

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons

A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY. Helen Mari Parsons A Culture of Quality? Lymph Node Evaluation for Colon Cancer Care A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Helen Mari Parsons IN PARTIAL FULFILLMENT

More information

Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer

Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer Survival Prediction Models for Estimating the Benefit of Post-Operative Radiation Therapy for Gallbladder Cancer and Lung Cancer Jayashree Kalpathy-Cramer PhD 1, William Hersh, MD 1, Jong Song Kim, PhD

More information

Gastrointestinal and Hernia Ward, Ningbo No.2 Hospital, Xibei Street 41, Ningbo, Zhejiang, China. * Equal contributors.

Gastrointestinal and Hernia Ward, Ningbo No.2 Hospital, Xibei Street 41, Ningbo, Zhejiang, China. * Equal contributors. Int J Clin Exp Med 2017;10(5):8165-8173 www.ijcem.com /ISSN:1940-5901/IJCEM0045461 Original Article Impact of primary tumor location on the overall survival of patients with stage IV colorectal cancer:

More information

The right middle lobe is the smallest lobe in the lung, and

The right middle lobe is the smallest lobe in the lung, and ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,

More information

Original / Cáncer The Inflammatory-Nutritional Index; assessing nutritional status and prognosis in gastrointestinal and lung cancer patients

Original / Cáncer The Inflammatory-Nutritional Index; assessing nutritional status and prognosis in gastrointestinal and lung cancer patients Nutr Hosp. 2014;29(3):629-634 ISSN 0212-1611 CODEN NUHOEQ S.V.R. 318 Original / Cáncer The Inflammatory-Nutritional Index; assessing nutritional status and prognosis in gastrointestinal and lung cancer

More information

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO Review and Impact of the NCDB PUF Moderator: Sandra Wong, MD, MS, FACS, FASCO Financial Disclosure I do not have personal financial relationships with any commercial interests Learning Objectives At the

More information

ESD for EGC with undifferentiated histology

ESD for EGC with undifferentiated histology ESD for EGC with undifferentiated histology Jun Haeng Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Biopsy: M/D adenocarcinoma ESD: SRC >>

More information

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival

Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival MOLECULAR AND CLINICAL ONCOLOGY 7: 1083-1088, 2017 Patient age and cutaneous malignant melanoma: Elderly patients are likely to have more aggressive histological features and poorer survival FARUK TAS

More information

Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada

Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada Does Anesthesia influence Cancer recurrence? Dr Ian McConachie FRCA FRCPC London, ON, Canada Why did my cancer come back? Inadequate resection Micro metastases Lymph spread Tumour biology Immune system

More information

How to improve the reliability of Single Arm Trials

How to improve the reliability of Single Arm Trials Workshop on Single Arm Trials in Oncology Products EMA, London, June 30, 2016 How to improve the reliability of Single Arm Trials Paolo Bruzzi Clinical Epidemiology Unit IRCCS San Martino-IST - National

More information

University of Groningen. Colorectal Anastomoses Bakker, Ilsalien

University of Groningen. Colorectal Anastomoses Bakker, Ilsalien University of Groningen Colorectal Anastomoses Bakker, Ilsalien IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document

More information

Surgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14

Surgical Management of Advanced Stage Colon Cancer. Nathan Huber, MD 6/11/14 Surgical Management of Advanced Stage Colon Cancer Nathan Huber, MD 6/11/14 Colon Cancer Overview Approximately 50,000 attributable deaths per year Colorectal cancer is the 3 rd most common cause of cancer-related

More information

Gene expression profiling predicts clinical outcome of prostate cancer. Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M.

Gene expression profiling predicts clinical outcome of prostate cancer. Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M. SUPPLEMENTARY DATA Gene expression profiling predicts clinical outcome of prostate cancer Gennadi V. Glinsky, Anna B. Glinskii, Andrew J. Stephenson, Robert M. Hoffman, William L. Gerald Table of Contents

More information

Differential lymph node retrieval in rectal cancer: associated factors and effect on survival

Differential lymph node retrieval in rectal cancer: associated factors and effect on survival Original Article Differential lymph node retrieval in rectal cancer: associated factors and effect on survival Cedrek McFadden 1, Brian McKinley 1, Brian Greenwell 2, Kaylee Knuckolls 1, Patrick Culumovic

More information

Evaluation of prognostic scoring systems for bone metastases using single center data

Evaluation of prognostic scoring systems for bone metastases using single center data MOLECULAR AND CLINICAL ONCOLOGY 3: 1361-1370, 2015 Evaluation of prognostic scoring systems for bone metastases using single center data HIROFUMI SHIMADA 1, TAKAO SETOGUCHI 2, SHUNSUKE NAKAMURA 1, MASAHIRO

More information

Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance

Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Original Article Lower lymph node yield following neoadjuvant therapy for rectal cancer has no clinical significance Dedrick Kok Hong Chan 1,2, Ker-Kan Tan 1,2 1 Division of Colorectal Surgery, University

More information

Is the number of lymph nodes retrieved in laparoscopic colorectal cancer resections related to the learning curve of the surgeon?

Is the number of lymph nodes retrieved in laparoscopic colorectal cancer resections related to the learning curve of the surgeon? ORIGINAL ARTICLE Is the number of lymph nodes retrieved in laparoscopic colorectal cancer resections related to the learning curve of the surgeon? O. Aly 1, E MacDonald 2, C Watkins 2, G I Murray 3, E

More information

Update: Chronic Lymphocytic Leukemia

Update: Chronic Lymphocytic Leukemia ASH 2008 Update: Chronic Lymphocytic Leukemia Improving Patient Response to Treatment with the Addition of Rituximab to Fludarabine-Cyclophosphamide ASH 2008: Update on chronic lymphocytic leukemia CLL-8

More information